NIKA · Nika Pharmaceuticals, Inc
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 10, 2026
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
NIKA Latest Reported Short Interest
FINRA reported 70 NIKA shares sold short as of the August 14, 2026 settlement date, an increase of 69 shares. Days to cover was 1.00 based on FINRA's reported average daily volume.
Official FINRA short-interest data · share counts are restated for subsequent stock splits
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-08-14). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-09-15
Scheduled
FINRA publishes Sep 24
|
— | — | — | — |
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
| 2026-08-14 | 70 | 1 | +69 | 1.00 |
| 2026-07-31 | 1 | 1 | 0 | 1.00 |
| 2026-07-15 | 1 | 1 | 0 | 1.00 |
| 2026-06-30 | 1 | 1 | 0 | 1.00 |
| 2026-06-15 | 1 | 1 | 0 | 1.00 |
| 2026-05-29 | 1 | 1 | 0 | 1.00 |
| 2026-05-15 | 1 | 1 | 0 | 1.00 |
| 2026-04-30 | 1 | 1 | 0 | 1.00 |
| 2026-04-15 | 1 | 1 | 0 | 1.00 |
| 2026-03-31 | 1 | 1 | 0 | 1.00 |
| 2026-03-13 | 1 | 0 | +1 | 1.00 |
Full FINRA short interest reporting calendar